An Active Health-Based Comprehensive Study on Diabetes Management
NCT ID: NCT07160998
Last Updated: 2026-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
124 participants
INTERVENTIONAL
2025-09-07
2025-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Actions & Insights Evaluating a Novel Diabetes Management Solution
NCT03638349
Multi-omics Mechanisms of Lifestyle Intervention in Regulating Blood Glucose
NCT07146308
A Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Diabetic Patients.
NCT02156349
A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.
NCT02268929
Evaluation of Morbidities, Endpoints and Reaching Targets in Diabetic Patients Managed by a Diabetes Specialist Team
NCT01690208
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
X Life AI Lifestyle Guidance
Personalized real-time lifestyle recommendations delivered via smartphone, tablet, etc., integrating glucose level and wearable data.
Digital Lifestyle Therapeutic
Personalized real-time lifestyle recommendations are delivered via via smartphone, tablet, etc., integrating glucose level and wearable data.
Standard Care
Participants receive standard diabetes management including medications and lifestyle recommendations based on guidelines.
Standard Care
Participants receive standard diabetes management including medications and lifestyle recommendations based on guidelines.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Digital Lifestyle Therapeutic
Personalized real-time lifestyle recommendations are delivered via via smartphone, tablet, etc., integrating glucose level and wearable data.
Standard Care
Participants receive standard diabetes management including medications and lifestyle recommendations based on guidelines.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed type 2 diabetes
* Stable medication regimen ≥ 3 months
* HbA1c 7-10%
* Smartphone access and ability to operate app
* Willing to wear CGM and activity tracker
* Able to provide informed consent
Exclusion Criteria
* Severe chronic/acute diabetic complications
* Early-onset diabetes (\<40 years at diagnosis)
* Severe cardiovascular disease, uncontrolled hypertension, active liver disease, malignancy
* Severe psychiatric or cognitive disorders
* Allergy to CGM materials
* Planned surgery or long-term travel during study
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Li Huating
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Li Huating
Shanghai 6th People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Sixth People's Hospital
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-122
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.